Effect of Cynodon dactylon on rotenone induced Parkinson's disease

Oriental Pharmacy and Experimental Medicine

Volumn 12, Issue 3, 2012, Pages 167-175

  Sharma, Neha ^a   Bafna, Pallavi ^a  

^a Rayat Institute of Pharmacy   (India)

Author keywords

Catalepsy; Cynodon dactylon; Oxidative stress; Parkinsons; Rotenone

Indexed keywords

ANTIPARKINSON AGENT; CATALASE; CYNODON DACTYLON EXTRACT; GLUTATHIONE; PLANT EXTRACT; ROTENONE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BERMUDA GRASS; BRAIN; CATALEPSY; CONTROLLED STUDY; CYNODON; FEMALE; LOCOMOTION; MALE; MUSCLE RIGIDITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 84865792281     PISSN: 15982386     EISSN: 22111069     Source Type: Journal    
DOI: 10.1007/s13596-012-0075-1     Document Type: Article

References (68)

1. Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 2nd edn. Chemic Academic Press, New York, pp 673-685.
2. Agharkar SP (1991) Medicinal plants of Bombay Presidency. Scientific Publishers, Mumbai, pp 80-87.
3. Alam M, Schmidt WJ (2002) Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136: 317-324.
4. Auddy B, Ferreira M, Blasina F, Lafon L, Arredondo F, Dajas F, Tripathi PC, Seal T, Mukherje B (2003) Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases. J Ethnopharmacol 84: 131-138.
5. Babu RDS, Neeharika V, Pallavi V, Reddy MB (2009) Antidiarrheal activity of Cynodon Dactylon. Pers Phcog Mag 5: 23-27.
6. Baskar AA, Ignacimuthu S (2010) Chemopreventive effect of Cynodon dactylon (L.) Pers. extract against DMH-induced colon carcinogenesis in experimental animals. Exp Toxicol Pathol 62(4): 423-431.
7. Betarbet R, Sherer TB, Greenamyre JT (2002) Animal models of Parkinson's disease. Bioessays 24(4): 308-318.
8. Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 6: 882-888.
9. Bishnoi M, Chopra K, Kulkarni SK (2006) Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes. Eur J Pharmacol 52(1-3): 55-66.
10. Bowler C, van Montagu M, Inzé D (1992) Superoxide dismutase and stress tolerance. Annu Rev Plant Physiol Plant Mo1 Biol 4(3): 86-116.
11. Chen L, Ding Y, Cagniard B, van Laar AD, Mortimer A, Chi W, Hastings TG, Kang UJ, Zhuang X (2008) Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci 28(2): 425-433.
12. Collier TJ, Sortwell CE (1999) Therapeutic potential of nerve growth factors in Parkinson's disease. Drug Aging 14: 261-287.
13. Costall B, Naylor RJ (1974) On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity. Psychopharmacologia 34(3): 233-241.
14. Dhanasekaran M, Tharakan B, Manyam BV (2008) Antiparkinson drug- Mucuna pruriens shows antioxidant and metal chelating activity. Phytother Res 22(1): 6-11.
15. Dexter DT, Carter CJ, Wells FR (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381-389.
16. Dexter DT, Holley AE, Flitter WD (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord 9: 92-97.
17. Dorval J, Hontela A (2003) Role of glutathione redox cycle and catalase in defence against oxidative stress induced by endosulfan in adrenocortical cells of rainbow trout (Oncorhynchus mykiss). Toxicol Appl Pharmacol 192(2): 191-200.
18. Emborg ME (2004) Evaluation of animal models of Parkinson's disease for neuroprotective strategies. J Neurosci Methods 139: 121-143.
19. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol: 259-272.
20. Garg VK, Paliwal SK (2011) Anti-inflammatory activity of aqueous extract of Cynodon dactylon. Int J Pharmacol 1-6.
21. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ (1998) The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50: 1346-1350.
22. Gralla EB, Kosman DJ (1992) Molecular genetics of superoxide dismutases in yeasts and related fungi. Adv Genet 30: 251-319.
23. Grillner S, Kotaleski JH, Menard A, Saitoh K, Wikstrom M (2005) Mechanisms for selection of basic motor programs-roles for the striatum and pallidum. Trends Neurosci 28: 364-370.
24. Halegrahara N, Ponnusamy K (2010) Neuroprotective effect of Centella asiatica extract (CEA) on experimentally induced parkinsonism in aged Sprague-Dawley rats. J Toxicol Sci 35: 41-47.
25. Halliwell B, Gutteridge J (1985) Oxygen radicals and the nervous system. Trends Neurosci 8: 22-29.
26. Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL (1998) Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 780: 294-303.
27. Jenner P, Olanow CW (1998) Understanding cell death in Parkinson's disease. Ann Neurol 44: S72-S84.
28. Karch AM (2009) Focus on nursing pharmacology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, p 3.
29. Knight TR, Fariss MW, Farhood A, Jaeschke H (2003) Role of lipid peroxidation as mechanism of liver injury after acetaminophen overdose in mice. Toxicol Sci 76(1): 229-236.
30. Kulkarni SK (2008) Handbook of experimental pharmacology. Vallabh Prakashan, Delhi, pp 136-137.
31. Kumar R, Bheemachari PM, Bansal R, Singh L (2010) Evaluation of antiepileptic activity of leaf extract of Cynodon dactylon in validated animal models. Int J Pharmacy Res 1(2): 65-73.
32. Lang AE, Lozano AM (1998) Parkinson's disease. N Engl J Med 339: 1130.
33. Lapointe N, St-Hilaire M, Martinoli MG, Blanchet J, Gould CR, Cicchetti F (2004) Rotenone induces non-specific central nervous and systemic toxicity. FASEB J 18: 717-719.
34. Lotharius J, O'Malley KL (2000) The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem 275: 38581-38588.
35. McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglias are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285-1291.
36. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex-I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163: 1450-1455.
37. Monk LS, Fagerstedt KV, Crawford RM (1989) Oxygen toxicity and superoxide dismutase as an antioxidant in physiological stress. Physiol Plant 76: 456-459.
38. Najafi M, Nazemiyeh H, Ghavimi H, Gharakhani A, Garjani A (2008) Effects of hydroalcoholic extract of Cynodon dactylon (L.) pers. on ischemia/reperfusion-induced arrhythmias. DARU 16(4): 233-238.
39. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thio-barbituric acid reaction. Anal Biochem 95: 351-358.
40. Pal DK (2009) Determination of brain biogenic amines in Cynodon dactylon pers. and Cyperus rotundus treated mice. Int J Pharmacy Pharm Sci 1(1): 190-197.
41. Parekh J, Chanda SV (2007) In vitro antimicrobial activity and phytochemical analysis of some Indian medicinal plants. Turk J Biol 31: 53-58.
42. Parekh J, Jadeja D, Chanda S (2005) Efficacy of aqueous and methanol extracts of some medicinal plants for potential antibacterial activity. Turk J Biol 29: 203-210.
43. Patdi AK (2010) Cynodon, Durba Grass, An Ayurvedic Medicinal Grass Grown In India (Press release).
44. Patil M, Jalalpure SS, Prakash NS, Kokate CK (2005) Anti ulcer properties of Cynodon dactylon extracts in rats. Acta Horticulturae 680: 115.
45. Rai PK, Jaiswal D, Rai DK, Sharma B, Watal G (2010) Antioxidant potential of oral feeding of Cynodon dactylon extract on diabetes-induced oxidative stress. J Food Biochem 34: 78-92.
46. Samantaray S, Knaryan VH, Guyton MK, Matzelle DD, Ray SK, Banik N (2007) The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience 146(2): 741-755.
47. Santhi R, Annapoorani S (2010) Efficacy of Cynodon dactylon for immunomodulatory activity. Drug Invention Today 2(2): 112-114.
48. Saravanan KS, Sindhu KM, Senthilkumar KS, Mohanakumar KP (2006) L Deprenyl protects against rotenone-induced, oxidative stress mediated dopaminergic neurodegeneration in rats. Neurochem Int 49: 28-40.
49. Saravanan KS, Sindhu KM, Mohanakumar KP (2007) Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model. J Pineal Res 42(3): 247-253.
50. Scandalios JG (1990) Response of plant antioxidant defense genes to environmental stress. Adv Genet 28: 1-41.
51. Schmidt WJ, Alam M (2006) Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD). J Neural Transm 70: 273-276.
52. Scott L (2006) Identifying poor symptom control in Parkinson's disease. Nurs Times 2: 30-32.
53. Shabi MM, Gayathri K, Venkatalakshmi R, Sasikala C (2010) Chemical Constituents of hydro alcoholic extract and phenolic fraction of Cynodon dactylon. Int J Chem Tech Res 2(1): 149-154.
54. Neha S, Rana AC, Bafna PA (2011) Effect of aqueous extract of Cynodon dactylon on reserpine induced catalepsy. Int J Pharmacy Pharm Sci 3(4): 424-426.
55. Sherer TB, Betarbet R, Greenamyre JT (2002) Environment, mitochondria and Parkinson's disease. Neuroscientist 8: 192-197.
56. Sherer TB, Betarberbet R, Tasta CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Yagi AM, Greenamyre JT (2003) Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 23(340): 10756-10764.
57. Sherer TB, Richardson JR, Testa CM, Seo BB, Panov AV, Yagi T, Matsuno-Yagi A, Miller GW, Greenamyre JT (2007) Mechanism of toxicity of pesticides acting at complex 1: relevance to environmental etiologies of Parkinson's disease. J Neurochem 100(6): 1469-1479.
58. Shivalinge Gowda KP, Satish S, Mahesh CM, Kumar V (2009) Study on the diuretic activity of Cynodon dactylon root stalk extract in albino rats. Res J Pharm Tech 2(2): 338-340.
59. Singh SK, Kesari AN, Gupta RK, Jaiswal D, Watal G (2007) Assessment of antidiabetic potential of Cynodon dactylon extract in streptozotocin diabetic rats. J Ethnopharmacol 114(2): 174-179.
60. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388: 839-840.
61. 4- induced in rats. Phcog Mag 4: 195-201.
62. Verma R, Nehru B (2009) Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. Neurochem Int 55: 369-375.
63. Wang HD, Pagano PJ, Du Y, Cayatte AJ, Quinn MT, Brecher P, Cohen RA (1998) Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 82: 810-818.
64. Wooten GF (1997) Neurochemistry and neuropharmacology of Parkinson's disease. In: Watts RL, Koller O (eds) Movement disorders; neurologic principles and practice. McGraw Hill, New York, pp 153-160.
65. Yang SF, Yangk ZQ, Wu Q, Sun AS, Huang XN, Shi JS (2001) Protective effect and mechanism of Ginkgo biloba leaf extracts for Parkinson's disease induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Acta Pharmacol Sinica 22(12): 1089-1093.
66. Yong R, Liu RW, Jiang H, Jiang Q, Feng J (2005) Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem 280(40): 34105-34112.
67. Zigmond MJ, Stricker EM (1989) Animal models of parkinsonism using selective neurotoxins: clinical and basic implications. Int Rev Neurobiol 31: 1-79.
68. 2 release at mitochondria complex-1. J Biol Chem 280(16): 15587-15594.